NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email British business confidence has weakened this month after executives’ view of the global economic outlook declined to its darkest in a year, a survey by Lloyds showed on Friday.Read More